Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
HilleVax, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 SC 13G Deep Track Capital, LP reports a 6.1% stake in HilleVax, Inc.
09/27/2023 SC 13D/A Frazier Life Sciences Public Fund, L.P. reports a 20.2% stake in HilleVax, Inc.
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: "HilleVax Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress BOSTON, August 14, 2023"
05/12/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
05/12/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/09/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/05/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/25/2023 8-K Quarterly results
04/18/2023 8-K Quarterly results
03/17/2023 10-K Annual Report for the period ended December 31, 2022
03/17/2023 8-K Quarterly results
Docs: "HilleVax Reports Full Year 2022 Financial Results and Highlights Recent Company Progress BOSTON, March 17, 2023"
02/14/2023 SC 13G RA CAPITAL MANAGEMENT, L.P. reports a 5.3% stake in HILLEVAX, INC.
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Flynn James E reports a 8.1% stake in HilleVax, Inc.
01/09/2023 8-K Investor presentation
Docs: "Slide Presentation",
"Slide Presentation"
09/08/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/31/2022 8-K Quarterly results
08/10/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/10/2022 8-K Quarterly results
06/08/2022 10-Q Quarterly Report for the period ended March 31, 2022
06/08/2022 8-K Quarterly results
05/13/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/13/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/09/2022 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
05/06/2022 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
05/03/2022 SC 13G Flynn James E reports a 7.8% stake in Hillevax, Inc.
05/03/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : May 3, 2022 HILLEVAX, INC. Delaware 001-41365 85-0545060 75 State Street, Suite 100 - #9995 Boston, Massachusetts 02109 213-5054 N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the...",
"Amended and Restated Certificate of Incorporation of HilleVax, Inc",
"Amended and Restated Bylaws of HilleVax, Inc"
04/29/2022 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
04/29/2022 EFFECT Form EFFECT - Notice of Effectiveness:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy